BCR and non-Hodgkin lymphoma: A comprehensive understanding of the intricate mechanisms underpinning BCR-mediated lymphomagenesis not only elucidates the molecular landscape of NHL but also holds promise for the development of novel therapeutic strategies aimed at targeting this pathway for more effective B cell NHL treatment [6].